ES2170855T3 - Derivados de 1,4-benzodioxina. - Google Patents
Derivados de 1,4-benzodioxina.Info
- Publication number
- ES2170855T3 ES2170855T3 ES96913732T ES96913732T ES2170855T3 ES 2170855 T3 ES2170855 T3 ES 2170855T3 ES 96913732 T ES96913732 T ES 96913732T ES 96913732 T ES96913732 T ES 96913732T ES 2170855 T3 ES2170855 T3 ES 2170855T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- sub
- hydrogen atom
- atom
- ariloxi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE DESCRIBE UN DERIVADO DE 1,4 OALQUILO C SUB,3} ALMENTE UN ATOMO DE HIDROGENO, UN ATOMO DE HALOGENO, UN GRUPO ALQUILO, UN GRUPO TRIFLUOROMETILO, UN GRUPO ALCOXI, UN GRUPO ARILO, UN GRUPO ARILOXI, O R SUB,1} Y R SUB,2} JUNTOS FORMAN UN GRUPO METILENDIOXI, R SUB,3} ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO, R SUB,4} ES UN ATOMO DE HIDROGENO O CO SUB,2}R SUB,5}, R SUB,5} ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO, X ES UN RADICAL DE FORMULA (II) O (III) EN LAS CUALES N ES 1 O 2. LOS COMPUESTOS RESULTAN UTILES PARA UN AGENTE PROFILACTICO O TERAPEUTICO PARA LA DIABETES, LA HIPERGLUCEMIA O LA OBESIDAD.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13744095 | 1995-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2170855T3 true ES2170855T3 (es) | 2002-08-16 |
Family
ID=15198681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96913732T Expired - Lifetime ES2170855T3 (es) | 1995-05-12 | 1996-05-13 | Derivados de 1,4-benzodioxina. |
Country Status (8)
Country | Link |
---|---|
US (1) | US6130243A (es) |
EP (1) | EP0825189B1 (es) |
JP (1) | JP3068198B2 (es) |
KR (1) | KR100490003B1 (es) |
CA (1) | CA2220759C (es) |
DE (1) | DE69618634T2 (es) |
ES (1) | ES2170855T3 (es) |
WO (1) | WO1996035685A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0947498B1 (en) | 1996-12-02 | 2004-09-15 | Chisso Corporation | Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same |
HUP0000768A2 (hu) * | 1996-12-30 | 2001-05-28 | American Home Products Corporation | Szubsztituált benzo[1,4]dioxánok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények |
US5965607A (en) * | 1996-12-30 | 1999-10-12 | American Home Products Corporation | Substituted Benzo[1,4]dioxines as antiobesity agents |
KR100523713B1 (ko) | 1998-07-31 | 2005-10-26 | 닛신 파마 가부시키가이샤 | 광학활성 1,4-벤조디옥신-2-카르복실산 유도체 및 그의제조방법 |
WO2003024953A1 (fr) * | 2000-08-10 | 2003-03-27 | Nisshin Pharma Inc. | Derive de propanolamine a noyau 1,4-benzodioxane |
JP2002053574A (ja) | 2000-08-10 | 2002-02-19 | Nisshin Pharma Inc | 1,4−ベンゾジオキサン環を有するプロパノールアミン誘導体 |
US7604206B2 (en) | 2001-11-19 | 2009-10-20 | Samsung Electronics Co., Ltd. | Monitor improved in a tilting and combining structure |
US20030236213A1 (en) * | 2002-04-10 | 2003-12-25 | Jean-Louis Dasseux | Mimics of acyl coenzyme-A comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
EP1512677A4 (en) * | 2002-06-11 | 2007-06-20 | Kaneka Corp | PROCESS FOR PRODUCING OPTICALLY ACTIVE $ G (B) -AMINOALCOOL |
JPWO2004070045A1 (ja) * | 2003-02-10 | 2006-05-25 | 日清ファルマ株式会社 | 光学活性な6−ホルミル−1,4−ベンゾジオキシン−2−カルボン酸誘導体の製造方法 |
WO2005083102A1 (ja) * | 2004-03-01 | 2005-09-09 | Mercian Corporation | 光学活性1,4-ベンゾジオキシン-2-カルボン酸誘導体の製造方法 |
TW200740779A (en) * | 2005-07-22 | 2007-11-01 | Mitsubishi Pharma Corp | Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
JPWO2007139062A1 (ja) * | 2006-05-30 | 2009-10-08 | 杏林製薬株式会社 | 肥満治療剤並びに肥満の治療及び予防方法 |
WO2007145203A1 (ja) * | 2006-06-13 | 2007-12-21 | Daiichi Fine Chemical Co., Ltd. | 光学活性2-アミノ-1-(4-フルオロフェニル)エタノール |
US10052326B1 (en) | 2017-10-12 | 2018-08-21 | King Saud University | Antihepatotoxic agents |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4205079A (en) * | 1978-10-16 | 1980-05-27 | Shell Oil Company | Benzodioxincarboxamides |
EP0023385B1 (en) * | 1979-06-16 | 1982-12-15 | Beecham Group Plc | Ethanamine derivatives, their preparation and use in pharmaceutical compositions |
US5061727A (en) * | 1990-05-04 | 1991-10-29 | American Cyanamid Company | Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles |
DK0608568T3 (da) * | 1993-01-29 | 1998-09-28 | American Cyanamid Co | Aminocycloalkanobenzodioxoler som beta 3-selektiveadrenerge midler |
JPH06293664A (ja) * | 1993-04-05 | 1994-10-21 | Fujisawa Pharmaceut Co Ltd | β3−アドレナリン作動薬の新規医薬用途 |
US5482971A (en) * | 1993-10-01 | 1996-01-09 | American Cyanamid Company | Beta3 -adrenergic agents and their use in pharmaceutical compositions |
JPH07228543A (ja) * | 1994-02-16 | 1995-08-29 | Fujisawa Pharmaceut Co Ltd | β3−アドレナリン作動薬の新規医薬用途 |
-
1996
- 1996-05-13 CA CA002220759A patent/CA2220759C/en not_active Expired - Fee Related
- 1996-05-13 KR KR1019970708082A patent/KR100490003B1/ko not_active IP Right Cessation
- 1996-05-13 WO PCT/JP1996/001252 patent/WO1996035685A1/ja active IP Right Grant
- 1996-05-13 ES ES96913732T patent/ES2170855T3/es not_active Expired - Lifetime
- 1996-05-13 DE DE69618634T patent/DE69618634T2/de not_active Expired - Fee Related
- 1996-05-13 JP JP8533953A patent/JP3068198B2/ja not_active Expired - Fee Related
- 1996-05-13 EP EP96913732A patent/EP0825189B1/en not_active Expired - Lifetime
- 1996-05-13 US US08/945,879 patent/US6130243A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1996035685A1 (fr) | 1996-11-14 |
DE69618634D1 (de) | 2002-02-28 |
EP0825189A4 (en) | 1998-08-05 |
EP0825189B1 (en) | 2002-01-02 |
EP0825189A1 (en) | 1998-02-25 |
CA2220759A1 (en) | 1996-11-14 |
CA2220759C (en) | 2009-01-20 |
KR100490003B1 (ko) | 2005-12-21 |
US6130243A (en) | 2000-10-10 |
KR19990014740A (ko) | 1999-02-25 |
JP3068198B2 (ja) | 2000-07-24 |
DE69618634T2 (de) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2170855T3 (es) | Derivados de 1,4-benzodioxina. | |
IS6472A (is) | 2-oxó-1-pýrrólidín afleiður, aðferð til framleiðslu á þeim og notkun þeirra | |
SE8503680D0 (sv) | Indolderivat | |
PT863875E (pt) | Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal | |
DK0841928T3 (da) | Sustained release-formulering af d-threo-methylphenidat | |
DK0766668T3 (da) | Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf | |
ES530901A0 (es) | Procedimiento para preparar derivados de piperazina | |
ATE211732T1 (de) | N-benzylpiperidin- und tetrahydropyridin-derivate | |
ES529811A0 (es) | Procedimiento para preparar derivados de n-fenil-benzamida | |
ATE120164T1 (de) | Flüssigphase-fluorieren. | |
ES2059724T3 (es) | Un procedimiento para preparar derivados de purinil piperacina 6-sustituidos. | |
ES2166470T3 (es) | Derivados de indolalquilo de la benzodioxanmetilamina como ligandos de los receptores 5-ht1a. | |
DK0550612T3 (da) | Ny fremgangsmåde til fremstilling af formoterol ogbeslægtede forbindelser | |
FI101376B1 (fi) | Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi | |
AR000813A1 (es) | Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas | |
DK326481A (da) | Fremgangsmaade til fremstilling af i 5-stillingen substituerede 5,10-dihydro-11h-dibenzo (b,e) (1,4) diazepin-11-oner eller syreadditionssalte deraf | |
ES2162078T3 (es) | Compuestos terapeuticos. | |
AU545216B2 (en) | 2-(4-benzylpiperidino)-1-(4 halo-phenyl)piopan-1-ol | |
ATE126799T1 (de) | Derivate von methylpiperazinoazepin, verfahren zu ihrer herstellung und verwendung. | |
DK104388A (da) | Hidtil ukendte 2-(2,3-dihydro-2-oxo-3-benzofuranyl)-eddikesyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem | |
FI824155A0 (fi) | Foerfarande foer framstaellning av 3,7a-diazacyklohepta/j,k/fluoren | |
AR003529A1 (es) | Derivados de alfa-fenilpiperidin-1-propanol, procedimiento para su preparacion y su aplicacion terapeutica. | |
ES2115301T3 (es) | Procedimiento para la preparacion de 2-cianoimino-tiazolidina. | |
DK0521766T3 (da) | Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater | |
ES511873A0 (es) | Procedimiento para la preparacion de 4-(4-fenil-1-piperidinil) metil-5-acil-1,3-dihidro-2h-imidazol-2-onas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 825189 Country of ref document: ES |